Figure 1: DIM plasma elimination for Control (non-formulated crystalline DIM), BioResponse DIM (BR-DIM) and F127-DIM formulation (F127-DIM), after oral administration to female Sprague-Dawley rats by aqueous gavage (3 mg/mL), at the dose of 60 mg/kg.